Italmatch Agrees Merger with Detrex

(c) SFIO CRACHO/Shutterstock
(c) SFIO CRACHO/Shutterstock

In its third deal so far this year, Italian specialty chemicals group Italmatch has agreed to acquire US company Detrex. Under the terms of the agreement, a newly formed subsidiary of Italmatch will buy Detrex for $27 per share in cash.

Based in Cleveland, Ohio, Detrex manufactures additives for industrial petroleum products, high-purity hydrochloric acid for the semiconductor industry and specialty chemicals. The company generated net sales of $37.5 million and EBITDA of $1.9 million in 2016.

The merger is expected to complete by Dec. 31, subject to the approval of at least two-thirds of Detrex’s shareholders, as well as the usual closing conditions. The companies said  directors and major shareholders representing approximately 52% of the US company’s shares have agreed to vote in favor of the proposal, unless a superior offer as defined in the agreement is received.

Thomas Mark, president and CEO of Detrex, called the merger a great opportunity to be part of an organization with deeper resources and operational scale in the specialty chemicals business.

For Italmatch, the acquisition brings highly complementary products, synergies and expanded geographical coverage. Sergio Iorio, managing director of Italmatch Chemicals Group, explained that Elco (Detrex’s operating subsidiary) has a distinctive and complementary position in extreme pressure (EP) additives and Ad-pack for grease and metalworking fluids. In addition, Elco brings a focus on markets in North America and Latin America, complementing Italmatch’s presence in Europe, Middle East & Africa.

Italmatch has been pursuing acquisitions in recent years as part of its strategy to develop and grow its business overseas. Its two other acquisitions this year were Sudamfos do Brasil in October and French start-up Magpie Polymers in July.                                               

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.